Caseware UK (AP4) 2025.0.111 2025.0.111 2025-12-312025-12-31No description of principal activityfalsefalse1242025-01-01131falsefalse 05447577 2025-01-01 2025-12-31 05447577 2024-01-01 2024-12-31 05447577 2025-12-31 05447577 2024-12-31 05447577 2024-01-01 05447577 1 2025-01-01 2025-12-31 05447577 1 2024-01-01 2024-12-31 05447577 5 2025-01-01 2025-12-31 05447577 5 2024-01-01 2024-12-31 05447577 1 2025-01-01 2025-12-31 05447577 d:ContinuingOperations 2025-01-01 2025-12-31 05447577 d:ContinuingOperations 2024-01-01 2024-12-31 05447577 d:DiscontinuedOperations 2025-01-01 2025-12-31 05447577 d:DiscontinuedOperations 2024-01-01 2024-12-31 05447577 e:Director1 2025-01-01 2025-12-31 05447577 e:Director2 2025-01-01 2025-12-31 05447577 e:Director2 2025-12-31 05447577 e:Director3 2025-01-01 2025-12-31 05447577 e:Director4 2025-01-01 2025-12-31 05447577 e:RegisteredOffice 2025-01-01 2025-12-31 05447577 e:Agent1 2025-01-01 2025-12-31 05447577 d:Buildings 2025-01-01 2025-12-31 05447577 d:Buildings 2025-12-31 05447577 d:Buildings 2024-12-31 05447577 d:Buildings d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 05447577 d:FurnitureFittings 2025-01-01 2025-12-31 05447577 d:FurnitureFittings 2025-12-31 05447577 d:FurnitureFittings 2024-12-31 05447577 d:FurnitureFittings d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 05447577 d:OfficeEquipment 2025-01-01 2025-12-31 05447577 d:OfficeEquipment 2025-12-31 05447577 d:OfficeEquipment 2024-12-31 05447577 d:OfficeEquipment d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 05447577 d:ComputerEquipment 2025-01-01 2025-12-31 05447577 d:ComputerEquipment 2025-12-31 05447577 d:ComputerEquipment 2024-12-31 05447577 d:ComputerEquipment d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 05447577 d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 05447577 d:CurrentFinancialInstruments 2025-12-31 05447577 d:CurrentFinancialInstruments 2024-12-31 05447577 d:CurrentFinancialInstruments d:WithinOneYear 2025-12-31 05447577 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 05447577 d:ReportableOperatingSegment1 2025-01-01 2025-12-31 05447577 d:ReportableOperatingSegment1 2024-01-01 2024-12-31 05447577 f:UnitedKingdom 2025-01-01 2025-12-31 05447577 f:UnitedKingdom 2024-01-01 2024-12-31 05447577 d:UKTax 2025-01-01 2025-12-31 05447577 d:UKTax 2024-01-01 2024-12-31 05447577 d:ShareCapital 2025-12-31 05447577 d:ShareCapital 2024-12-31 05447577 d:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 05447577 d:RetainedEarningsAccumulatedLosses 2025-12-31 05447577 d:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 05447577 d:RetainedEarningsAccumulatedLosses 2024-12-31 05447577 d:RetainedEarningsAccumulatedLosses 2024-01-01 05447577 d:AcceleratedTaxDepreciationDeferredTax 2025-12-31 05447577 d:AcceleratedTaxDepreciationDeferredTax 2024-12-31 05447577 d:OtherDeferredTax 2025-12-31 05447577 d:OtherDeferredTax 2024-12-31 05447577 e:OrdinaryShareClass1 2025-01-01 2025-12-31 05447577 e:OrdinaryShareClass1 2025-12-31 05447577 e:OrdinaryShareClass1 2024-12-31 05447577 e:FRS102 2025-01-01 2025-12-31 05447577 e:Audited 2025-01-01 2025-12-31 05447577 e:FullAccounts 2025-01-01 2025-12-31 05447577 e:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 05447577 d:WithinOneYear 2025-12-31 05447577 d:WithinOneYear 2024-12-31 05447577 d:PlantEquipmentOtherAssetsUnderOperatingLeases 2025-12-31 05447577 d:PlantEquipmentOtherAssetsUnderOperatingLeases 2024-12-31 05447577 d:PlantEquipmentOtherAssetsUnderOperatingLeases d:WithinOneYear 2025-12-31 05447577 d:PlantEquipmentOtherAssetsUnderOperatingLeases d:WithinOneYear 2024-12-31 05447577 d:PlantEquipmentOtherAssetsUnderOperatingLeases d:BetweenOneFiveYears 2025-12-31 05447577 d:PlantEquipmentOtherAssetsUnderOperatingLeases d:BetweenOneFiveYears 2024-12-31 05447577 g:PoundSterling 2025-01-01 2025-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered number: 05447577







ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 DECEMBER 2025


CAREMARK LIMITED







































 


CAREMARK LIMITED
 


 
COMPANY INFORMATION


Directors
Mr S A C Dalziel 
Miss L A Fyfe (resigned 5 September 2025)
Mr D J Glover 
Mr D Hirst (appointed 30 September 2025)




Registered number
05447577



Registered office
C1 Yeoman Gate
Yeoman Way

Worthing

West Sussex

BN13 3QZ




Independent auditor
Menzies LLP
Chartered Accountants & Statutory Auditor

3000a Parkway

Whiteley

Hampshire

PO15 7FX




Bankers
HSBC Bank Plc
6 West Street

Horsham

West Sussex

RH12 1PE





 


CAREMARK LIMITED
 



CONTENTS



Page
Strategic report
1 - 2
Directors' report
3 - 6
Independent auditor's report
7 - 10
Statement of income and retained earnings
11
Statement of financial position
12
Statement of cash flows
13
Analysis of net debt
14
Notes to the financial statements
15 - 26


 


CAREMARK LIMITED
 


 
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025

Introduction
 
The directors present their strategic report of the Company for the year ended 31 December 2025.

Business review
 
Since Caremark’s incorporation in 2005, the Company has developed, and continues to develop, a model and system for the delivery of high-quality domiciliary and related care services which it licences pursuant to a franchise agreement to its 141 franchisees in the UK.

The Company receives a monthly advice and support fee from its franchisees, based on their turnover, for the ongoing support and guidance that is provided by the Company. The Company also charges a one-off Licence Fee for all new franchisees joining the Caremark network.

In December 2025, the Company sold its company-owned care office in West Sussex, see note 19.

The Company issued 15 new franchisee licenses during 2025, which was in line with the Company’s internal target, which is in excess of industry averages. The Company foresees the potential to continue this growth in 2026.

For the year ending 31 December 2025, network turnover increased by 11%. Profits before tax in 2025 increased by 3% to
£4,008,463. Turnover has increased at a higher rate than profit due to an increase in Administrative expenses and income and profits from the company-owned care operations decreasing in 2025.

In 2025 the Company received the top accolade in franchising when it was awarded the HSBC/British Franchise Association Franchisor of the Year award. In addition the Company saw continued growth in its franchisee satisfaction score following an independent survey of all its franchise owners reflecting high engagement and satisfaction within its franchisee network.
  
Overall, the Company performed well during 2025 and achieved most of its own internal targets and budgets.
 

Principal risks and uncertainties
 
The principal risks the Company faces are the recruitment and retention of care assistants, changes relating to future government policies and cyber security threats.

The domiciliary care industry faces great pressures in the recruitment and retention of care assistants. A significant shortage of care assistants and an ageing population, means that supply cannot keep up with demand, which creates individual stress and business risk for our franchisees.

The Company is confident that any risks and uncertainties can be mitigated and that it will seize the opportunities within the UK marketplace to ensure growth in turnover, network coverage and profitability.

Page 1

 


CAREMARK LIMITED
 



STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025

Financial and other key performance indicators
 
The financial and other key performance indicators are as follows:

2025
2024
Variance
Variance %

Turnover

£10,651,236

£9,723,946

£927,290
 
9.54%
 
Profit on ordinary activities before taxation

£4,008,463

£3,874,915

£133,548
 
3.44%
 
Cash at bank and in hand

£2,691,432

£4,845,864

(£2,154,432)
 
(44.45%)
 


This report was approved by the board and signed on its behalf.



Mr D J Glover
Director

Date: 1 September 2026

Page 2

 


CAREMARK LIMITED
 


 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025

The directors present their report and the financial statements for the year ended 31 December 2025.

Directors' responsibilities statement

The directors are responsible for preparing the Strategic Report, the Directors' Report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these financial statements, the directors are required to:


select suitable accounting policies for the Company's financial statements and then apply them consistently;

make judgments and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Results and dividends

The profit for the year, after taxation, amounted to £2,988,152 (2024 - £2,886,786).

The total distribution of dividends for the year ended 31 December 2025 was £4,485,117 (2024 - £6,400,395).

Directors

The directors who served during the year were:

Mr S A C Dalziel 
Miss L A Fyfe (resigned 5 September 2025)
Mr D J Glover 
Mr D Hirst (appointed 30 September 2025) 

Future developments

In 2024 the Company successfully introduced a national marketing levy to its network, to create a national marketing fund to further support its franchisees' growth, which will continue to be developed throughout 2026.

The directors are continually investigating the use of various technologies with the aim of streamlining the recruitment process and monitoring compliance of the Franchisee network.

The Company’s business model is being reviewed in detail with changes being made to ensure the company remains competitive and effective whilst delivering the highest standards of care.

Page 3

 


CAREMARK LIMITED
 


 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025

Engagement with employees

Caremark Limited are proud to have an open-door policy. Staff members are encouraged to talk to the Directors any time. The directors are available in person, via emails, Teams or phone. The CEO holds regular meetings with employees to share Company updates. The directors also share video newsletters to give an update about the Company as and when necessary, and communications via the company employee engagement app.

Every January, franchise support centre employees are invited to the Annual Conference where the directors give an update on the industry, annual performance of the network and risks and opportunities for the forthcoming year.

As part of the Performance Management System, all employees share with their managers, their career aspirations, how they wish to progress, and any skills they might need for development. They also have regular 1-2-1 meetings.

The Company communicates openly, how the external economic factors affect the business.

The Company have continued the flexibility of staff members working from home one day a week. In the last financial year, cadence of virtual meetings remained high, ensuring that staff members are fully engaged and do not feel isolated.

Disabled employees

Caremark Limited is an equal opportunities employer. The Company will always make reasonable adjustments for disabled workers right from the recruitment process. The Company policy clearly states that the candidates and members of staff are not disadvantaged when doing their job and/or treated less favourably than someone else, because of a protected characteristic. As per the policy, Equality and Dignity at Work, all staff members are required to complete a Health Declaration and evidence any disabilities where they think reasonable adjustments should be made. Staff equal opportunity monitoring system also helps identify any disability so that the company can support them further, for an excellent employee experience that increases productivity, employee satisfaction and motivation. The staff handbook and the initial training of Care assistants assess their functional skills, if they need any support with reading, writing, or putting the learnings into practice. Thoughtful considerations are made before a care assistant with special needs is allocated to look after a client.

As many staff are lone workers, the Company has a policy for their manager to be in regular contact with employees, as research shows that loneliness may result into poor mental wellbeing and potential disability, the Company views this as an important policy to be followed.

Those with disabilities may be at greater risk of poor general health and wellbeing, the Company has therefore produced a policy to have frequent and early discussions to identify and mitigate the risk of mental disability.

Matters covered in the Strategic Report

The Company has chosen in accordance with section 414C(11) of the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 to set out in the Company's strategic report information required by schedule 7 of the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 it must be stated in the Directors' Report that it has done so. This includes information that would have been included in the business review and the principal risks and uncertainties.

Disclosure of information to auditor

Each of the directors at the time when this Directors' Report is approved has confirmed that:
 
so far as the director is aware, there is no relevant audit information of which the Company's auditor is unaware, and

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company's auditor is aware of that information.

Page 4

 


CAREMARK LIMITED
 


 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025

Post balance sheet events

Subsequent to the year end, the company completed the purchase of a new property for £1.2 million and the sale of its existing property for £472,000 is currently in negotiation. These transactions took place after the reporting date and have therefore been treated as non-adjusting events in these financial statements.

Page 5

 


CAREMARK LIMITED
 


 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025


Auditor

Under section 487(2) of the Companies Act 2006Menzies LLP will be deemed to have been reappointed as auditor 28 days after these financial statements were sent to members or 28 days after the latest date prescribed for filing the accounts with the registrar, whichever is earlier.

This report was approved by the board and signed on its behalf.
 





Mr D J Glover
Director

Date: 1 September 2026

Page 6

 


CAREMARK LIMITED
 

img0c7a.png
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF CAREMARK LIMITED

Opinion


We have audited the financial statements of Caremark Limited (the 'Company') for the year ended 31 December 2025, which comprise the Statement of Income and Retained Earnings, the Analysis of Net Debt, the Statement of Financial Position, the Statement of Cash Flows and the related notes, including a summary of significant accounting policiesThe financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


give a true and fair view of the state of the Company's affairs as at 31 December 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Conclusions relating to going concern


In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.


Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.


Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditor's Report thereon. The directors are responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Page 7

 


CAREMARK LIMITED


img3099.png
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF CAREMARK LIMITED (CONTINUED)

Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


the information given in the Strategic Report and the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the Strategic Report and the Directors' Report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Directors' Report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.


Responsibilities of directors
 

As explained more fully in the Directors' Responsibilities Statement set out on page 3, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.


Page 8

 


CAREMARK LIMITED


img08ab.png
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF CAREMARK LIMITED (CONTINUED)

Auditor's responsibilities for the audit of the financial statements
 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor's Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.


Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
 
The Company is subject to laws and regulations that directly affect the financial statements including financial reporting legislation, and general regulations such as health and safety. There are no industry specific laws and regulations which would be deemed to have a significant impact on the financial statements. We assessed the extent of compliance with the appropriate laws and regulations as part of our procedures on the related financial statement items.
 
We understood how the Company is complying with the legal and regulatory frameworks by, making inquiries to management.
 
The engagement partner assessed whether the engagement team collectively had the appropriate competence and capabilities to identify or recognize non-compliance with laws and regulations. The assessment did not identify any issues in this area.
 
We assessed the susceptibility of the Company financial statements to material misstatement, including how fraud might occur. Audit procedures performed by the engagement team included:
 
°Identifying and assessing the design effectiveness of controls management has in place to prevent and detect fraud;
°Understanding how those charged with governance considered and addressed the potential for override of controls or other inappropriate influence over the financial reporting process;
°Challenging assumptions and judgments made by management in its significant accounting estimates; and
°Identifying and testing journal entries, particularly any journal entries posted with unusual account combinations.
 
As a result of the above procedures, we considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the following areas:
 
°Posting of unusual journals and complex transactions.
°Misappropriation of funds through fraudulent purchase ledger and payroll payroll activity.
°Manipulation of amounts subject to significant judgment or estimate.


Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.


A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's Report.


Page 9

 


CAREMARK LIMITED


img2755.png
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF CAREMARK LIMITED (CONTINUED)

Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditor's Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.





Andrew Galliers FCA (Senior statutory auditor)
  
for and on behalf of
Menzies LLP
 
Chartered Accountants
Statutory Auditor
  
3000a Parkway
Whiteley
Hampshire
PO15 7FX

1 September 2026
Page 10

 


CAREMARK LIMITED
 


 
STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE YEAR ENDED 31 DECEMBER 2025

Continuing operations
Discontin'd operations
Total
Continuing operations
Discontinued operations
Total
2025
2025
2025
2024
2024
2024
Note
£
£
£
£
£
£

  

Turnover
 4 
8,696,721
1,954,515
10,651,236
7,650,552
2,073,394
9,723,946

Cost of sales
  
(162,067)
(1,334,340)
(1,496,407)
(85,537)
(1,345,670)
(1,431,207)

Gross profit
  
8,534,654
620,175
9,154,829
7,565,015
727,724
8,292,739

Administrative expenses
  
(4,859,320)
(521,422)
(5,380,742)
(4,056,540)
(548,870)
(4,605,410)

Operating profit
 5 
3,675,334
98,753
3,774,087
3,508,475
178,854
3,687,329

Profit/(loss) on disposal of discontinued operations
 19 
-
135,598
135,598
-
-
-

Interest receivable and similar income
 9 
98,778
-
98,778
191,881
-
191,881

Interest payable and similar expenses
 10 
-
-
-
(4,295)
-
(4,295)

Profit before tax
  
3,774,112
234,351
4,008,463
3,696,061
178,854
3,874,915

Tax on profit
 11 
(962,401)
(57,910)
(1,020,311)
(942,520)
(45,609)
(988,129)

Profit after tax
  
2,811,711
176,441
2,988,152
2,753,541
133,245
2,886,786

  

  

Retained earnings at the beginning of the year
  
4,821,985
8,335,594

  
4,821,985
 
8,335,594

Profit for the year
  
2,988,152
2,886,786

Dividends declared and paid
  
(4,485,117)
(6,400,395)

Retained earnings at the end of the year
  
3,325,020
 
4,821,985
The notes on pages 15 to 26 form part of these financial statements.

Page 11

 


CAREMARK LIMITED
REGISTERED NUMBER:05447577



STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 13 
328,645
359,230

  
328,645
359,230

Current assets
  

Debtors: amounts falling due within one year
 14 
1,968,385
1,391,949

Cash at bank and in hand
  
2,691,432
4,845,864

  
4,659,817
6,237,813

Creditors: amounts falling due within one year
 15 
(1,663,342)
(1,774,958)

Net current assets
  
 
 
2,996,475
 
 
4,462,855

Total assets less current liabilities
  
3,325,120
4,822,085

  

Net assets
  
3,325,120
4,822,085


Capital and reserves
  

Called up share capital 
 17 
100
100

Profit and loss account
 18 
3,325,020
4,821,985

  
3,325,120
4,822,085


The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Mr D J Glover
Director

Date: 1 September 2026

The notes on pages 15 to 26 form part of these financial statements.

Page 12

 


CAREMARK LIMITED
 



STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2025

2025
2024
£
£

Cash flows from operating activities

Profit for the financial year
2,988,152
2,886,786

Adjustments for:

Depreciation of tangible assets
35,517
45,929

Profit on disposal of tangible assets
(7,021)
132

Interest paid
-
4,295

Interest received
(98,778)
(191,881)

Taxation charge
1,020,311
988,129

(Increase)/decrease in debtors
(572,194)
324,692

(Decrease) in creditors
(125,561)
(392,823)

Corporation tax (paid)
(1,019,824)
(728,133)

Profit on disposal of discontinued operations
(135,598)
-

Net cash generated from operating activities

2,085,004
2,937,126


Cash flows from investing activities

Purchase of tangible fixed assets
(40,326)
(46,173)

Sale of tangible fixed assets
42,239
-

Interest received
98,778
191,882

Proceeds from sale of discontinued operations
135,598
-

Net cash from investing activities

236,289
145,709

Cash flows from financing activities

Repayment of loans
-
(189,268)

Dividends paid
(4,485,117)
(6,400,395)

Interest paid
-
(4,295)

Net cash used in financing activities
(4,485,117)
(6,593,958)

Net (decrease) in cash and cash equivalents
(2,163,824)
(3,511,123)

Cash and cash equivalents at beginning of year
4,845,864
8,356,987

Cash and cash equivalents at the end of year
2,682,040
4,845,864


Cash and cash equivalents at the end of year comprise:

Cash at bank and in hand
2,691,432
4,845,864

Bank overdrafts
(9,392)
-

2,682,040
4,845,864


The notes on pages 15 to 26 form part of these financial statements.

Page 13

 


CAREMARK LIMITED
 



ANALYSIS OF NET DEBT
FOR THE YEAR ENDED 31 DECEMBER 2025




At 1 January 2025
Cash flows
At 31 December 2025
£

£

£

Cash at bank and in hand

4,845,864

(2,154,432)

2,691,432

Bank overdrafts

-

(9,392)

(9,392)


4,845,864
(2,163,824)
2,682,040

The notes on pages 15 to 26 form part of these financial statements.

Page 14

 


CAREMARK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1.


General information

Caremark Limited is a private company limited by shares incorporated and domiciled in England and Wales.

The address of it's registered office, which is also the same as its principal place of business, is disclosed within the
Company Information page.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies (see note 3).

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.5

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 15

 


CAREMARK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.6

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


 
2.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 16

 


CAREMARK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)


2.8
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Freehold property
-
2%
Straight line (on buildings)
Fixtures and fittings
-
15%
Straight line
Office equipment
-
33%
Straight line
Computer equipment
-
33%
Straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

In the Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the Company's cash management.

 
2.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 17

 


CAREMARK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.12

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

 
2.13

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Judgements in applying accounting policies and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions
that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Fixed asset depreciation and residual values:

The directors have reviewed depreciation rates and asset lives & associated residual values of all fixed asset classes, and have concluded these are appropriate.

Page 18

 


CAREMARK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

4.


Turnover

An analysis of turnover by class of business is as follows:


2025
2024
£
£

Community service care franchising
10,651,236
9,723,946

10,651,236
9,723,946


Analysis of turnover by country of destination:

2025
2024
£
£

United Kingdom
10,651,236
9,723,946

10,651,236
9,723,946



5.


Operating profit

The operating profit is stated after charging:

2025
2024
£
£

Other operating lease rentals
30,781
27,857


6.


Auditor's remuneration

2025
2024
£
£

Fees payable to the Company's auditor for the audit of the Company's financial statements
23,100
22,000
Page 19

 


CAREMARK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

7.


Employees

Staff costs, including directors' remuneration, were as follows:


2025
2024
£
£

Wages and salaries
3,603,904
3,525,503

Social security costs
412,973
328,794

Cost of defined contribution scheme
61,764
60,591

4,078,641
3,914,888


The average monthly number of employees, including the directors, during the year was as follows:


        2025
        2024
            No.
            No.







Production and administration
124
131


8.


Directors' remuneration

2025
2024
£
£

Directors' emoluments
298,644
355,794

Company contributions to defined contribution pension schemes
1,932
2,525

300,576
358,319


During the year retirement benefits were accruing to 2 directors (2024 -2) in respect of defined contribution pension schemes.

The highest paid director received remuneration of £164,469 (2024 -£191,362).

The value of the Company's contributions paid to a defined contribution pension scheme in respect of the highest paid director amounted to £1,321 (2024 -£1,321).


9.


Interest receivable

2025
2024
£
£


Other interest receivable
98,778
191,881

98,778
191,881

Page 20

 


CAREMARK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

10.


Interest payable and similar expenses

2025
2024
£
£


Bank interest payable
-
4,295

-
4,295


11.


Taxation


2025
2024
£
£

Corporation tax


Current tax on profits for the year
966,643
935,271

Tax on disposal of discontinued operation
57,910
45,609


1,024,553
980,880


Total current tax
1,024,553
980,880

Deferred tax


Origination and reversal of timing differences
(4,242)
7,249

Total deferred tax
(4,242)
7,249


Total tax charge for the year
1,020,311
988,129

Factors affecting tax charge for the year

The tax assessed for the year is higher than (2024 -higher than) the standard rate of corporation tax in the UK of 25% (2024 -25%). The differences are explained below:

2025
2024
£
£


Profit on ordinary activities before tax
4,008,463
3,874,915


Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2024 -25%)
1,002,116
968,729

Effects of:


Expenses not deductible for tax purposes, other than goodwill amortisation and impairment
15,369
14,559

Other timing differences leading to an increase (decrease) in taxation
2,826
4,841

Total tax charge for the year
1,020,311
988,129

Page 21

 


CAREMARK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

12.


Dividends

2025
2024
£
£


Dividends analysis
4,485,117
6,400,395

4,485,117
6,400,395


13.


Tangible fixed assets


Freehold property
Fixtures and fittings
Office equipment
Computer equipment
Total

£
£
£
£
£



Cost or valuation


At 1 January 2025
374,325
146,754
18,454
131,868
671,401


Additions
-
10,515
856
28,955
40,326


Disposals
-
(42,680)
(14,936)
(103,983)
(161,599)



At 31 December 2025

374,325
114,589
4,374
56,840
550,128



Depreciation


At 1 January 2025
102,242
100,641
14,350
94,938
312,171


Charge for the year on owned assets
7,484
6,918
1,865
19,250
35,517


Disposals
-
(28,140)
(13,846)
(84,219)
(126,205)



At 31 December 2025

109,726
79,419
2,369
29,969
221,483



Net book value



At 31 December 2025
264,599
35,170
2,005
26,871
328,645



At 31 December 2024
272,083
46,113
4,104
36,930
359,230

Page 22

 


CAREMARK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

14.


Debtors

2025
2024
£
£


Trade debtors
1,272,967
260,840

Other debtors
105,161
64,131

Prepayments and accrued income
578,417
1,059,380

Deferred taxation
11,840
7,598

1,968,385
1,391,949



15.


Creditors: Amounts falling due within one year

2025
2024
£
£

Bank overdrafts
9,392
-

Trade creditors
343,298
490,576

Corporation tax
485,433
480,880

Other taxation and social security
453,499
350,603

Other creditors
44,540
45,487

Accruals and deferred income
327,180
407,412

1,663,342
1,774,958


Page 23

 


CAREMARK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

16.


Deferred taxation




2025


£






At beginning of year
7,598


Credited to the profit or loss
4,242



At end of year
11,840

The deferred tax asset is made up as follows:

2025
2024
£
£


Accelerated capital allowances
9,900
6,978

Short term timing differences
1,940
620

11,840
7,598


17.


Share capital

2025
2024
£
£
Authorised, allotted, called up and fully paid



10,000 (2024 -10,000) Ordinary shares of £0.01 each
100
100

Each Ordinary shareholder has one vote per Ordinary share held.



18.


Reserves

Profit and loss account

This reserve records retained earnings.

Page 24

 


CAREMARK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

19.


Discontinued operations

On 8th December 2025 Caremark Limited sold it's company-owned care office (Pulborough franchise) resulting in a profit on disposal of £135,598.

£


Cash proceeds
168,333

168,333

Net assets disposed of:


Tangible fixed assets
32,735

 
 
(32,735)

Profit on disposal before tax
135,598

The net inflow of cash in respect of the sale of the Pulborough franchise and its associated assets is as follows:

£


Cash consideration
168,333

Net inflow of cash
168,333


20.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund.  Contributions totalling £13,308 (2024 - £5,893) were payable to the fund at the reporting date and are included in creditors.

Page 25

 


CAREMARK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

21.


Commitments under operating leases

At 31 December 2025 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2025
2024
£
£

Land & Buildings


Not later than 1 year
-
16,372

-
16,372

2025
2024

£
£

Motor Vehicles


Not later than 1 year
10,832
10,832

Later than 1 year and not later than 5 years
1,741
10,095

12,573
20,927


22.


Related party transactions

Caremark International Limited is a company under common control. During the year, the company made purchases of £10,345 (2024: £7,653) on behalf of Caremark International Limited.

At the year end, an amount was owed by Caremark International Limited to the Company of £68,453 (2024 - £60,131).

Blue Frog Cleaning Services Limited is a company under common control. During the year, the company made purchases of £nil  (2024: £807) on behalf of Blue Frog Cleaning Services Limited. At the year end, an amount was owed by Blue Frog Cleaning Services Limited to the company of £441 (2024 - £nil).


23.


Post balance sheet events

Subsequent to the year end, the company completed the purchase of a new property for £1.2 million and the sale of its existing property for £472,000 is currently in negotiation. These transactions took place after the reporting date and have therefore been treated as non-adjusting events in these financial statements.

 
Page 26